Disc Medicine (IRON) EBIT (2020 - 2026)
Disc Medicine's (IRON) quarterly EBIT came in at -$69.5 million in Q1 2026, down 74.04% year-on-year from -$267.9 million in Q1 2025, and down 3.81% on a QoQ basis from -$67.0 million in Q4 2025.
Disc Medicine (IRON) EBIT (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of EBIT data on file, last reported at -$69.5 million in Q1 2026.
- On a quarterly basis, EBIT fell 74.04% year-over-year to -$69.5 million in Q1 2026; TTM through Mar 2026 was -$265.6 million, a 92.18% decrease from a year earlier, with the FY2025 full-year figure at -$236.0 million, down 81.95% from the prior year.
- EBIT for Q1 2026 stood at -$69.5 million, down from -$67.0 million in the prior quarter.
- Over the last five years, EBIT for IRON reached as high as -$10.0 million in Q1 2022 and fell as low as -$69.5 million in Q1 2026.
- Historically, EBIT has averaged -$33.8 million across 5 years, with a median of -$30.9 million in 2024.
- On a YoY basis, EBIT climbed as much as 43.2% in 2022 and fell as far as 173.9% in 2022.
- Year by year, EBIT stood at -$15.0 million in 2022, then sank by 97.82% to -$29.7 million in 2023, then decreased by 16.28% to -$34.6 million in 2024, then slumped by 93.84% to -$67.0 million in 2025, then fell by 3.81% to -$69.5 million in 2026.
- Per Business Quant data, the three most recent EBIT figures were -$69.5 million in Q1 2026, -$67.0 million in Q4 2025, and -$67.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Disc Medicine | 2.86 Bn | 2.86 Bn | - | -69.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.52 Mn |
| Dec 31, 2025 | -66.97 Mn |
| Sep 30, 2025 | -67.70 Mn |
| Jun 30, 2025 | -61.41 Mn |
| Mar 31, 2025 | -39.95 Mn |
| Dec 31, 2024 | -34.55 Mn |
| Sep 30, 2024 | -32.86 Mn |
| Jun 30, 2024 | -30.85 Mn |
| Mar 31, 2024 | -31.46 Mn |
| Dec 31, 2023 | -29.71 Mn |
| Sep 30, 2023 | -18.96 Mn |
| Jun 30, 2023 | -17.33 Mn |
| Mar 31, 2023 | -25.13 Mn |
| Dec 31, 2022 | -15.02 Mn |
| Sep 30, 2022 | -10.48 Mn |
| Jun 30, 2022 | -12.02 Mn |
| Mar 31, 2022 | -9.96 Mn |
| Dec 31, 2021 | 20.33 Mn |
| Sep 30, 2021 | -18.45 Mn |
| Jun 30, 2021 | -16.32 Mn |